Chang-Wook Nam

Showing 1-6 of 6 articles

Coronary interventions

Clinical outcomes of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention By Coronary Flow Capacity Status in Stable Lesions

Hamaya R, Lee J, Hoshino M, Yonetsu T, Koo B, Escaned J, Kakuta T, Kanaji Y, Kanno Y, Hada M, Yuki H, Yamaguchi M, Ohya H, Sumino Y, Hirano H, Horie T, Usui E, Sugano A, Sugiyama T, Murai T, Lee T, Choi K, Hwang D, Park J, Jung J, Kim H, Jung HW, Cho Y-K, Yoon H-J, Song YB, Hahn J, Doh J, Nam C, Shin E, Hur S-H, Mejía-Rentería H, Lauri F, Goto S, Macaya F, McInerney A, Gravina G, Vera R, Gonzalo N, Jimenez-Quevedo P, Núñez-Gil I, Salinas P, Nombela-Franco L, Del Trigo M, Fernández-Ortíz A, Macaya C

July 7, 2020 | 10.4244/EIJ-D-20-00401

Coronary interventions

Influence of target vessel on prognostic relevance of fractional flow reserve after coronary stenting

Hwang D, Lee J, Lee H, Kim S, Nam C, Hahn J, Shin E, Matsuo A, Tanaka N, Matsuo H, Lee S, Doh J, Koo B

August 29, 2019 | 10.4244/EIJ-D-18-00913

Prognosis of deferred non-culprit lesions according to fractional flow reserve in patients with acute coronary syndrome

Lee J, Choi K, Koo B, Shin E, Nam C, Doh J, Hwang D, Park J, Zhang J, Lim H, Yoon M-H, Tahk S

October 11, 2017 | 10.4244/EIJ-D-17-00110

Coronary interventions

Safety and efficacy of intracoronary nicorandil as hyperaemic agent for invasive physiological assessment: a patient-level pooled analysis

Lee J, Kato D, Oi M, Toyofuku M, Takashima H, Waseda K, Amano T, Kurita A, Ishihara H, Lim W-H, Doh J, Nam C, Tanaka N, Koo B, Tanaka N

June 10, 2016 | 10.4244/EIJV12I2A34

Usefulness of combined intravascular ultrasound parameters to predict functional significance of coronary artery stenosis and determinants of mismatch

Cho Y-K, Nam C, Han J-K, Koo B, Doh J, Ben-Dor I, Waksman R, Pichard A, Murata N, Tanaka N, Lee C-H, Gonzalo N, Escaned J, Costa M, Kubo T, Akasaka T, Hu X, Wang J-A, Yang H-M, Yoon M-H, Tahk S, Yoon H-J, Chung I-S, Hur S-H, Kim K-B

June 19, 2015 | 10.4244/EIJV11I2A30

Hybrid iFR-FFR decision-making strategy: implications for enhancing universal adoption of physiology-guided coronary revascularisation

Petraco R, Park J, Sen S, Nijjer S, Malik I, Echavarría-Pinto M, Asrress K, Nam C, Macías E, Foale R, Sethi A, Mikhail G, Kaprielian R, Baker C, Lefroy D, Bellamy M, Al-Bustami M, Khan M, Gonzalo N, Hughes A, Francis D, Mayet J, Di Mario C, Redwood S, Escaned J, Koo B, Davies J

February 22, 2013 | 10.4244/EIJV8I10A179

1

Latest news

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Valvular disease